Tower Research Capital LLC (TRC) - NEXIMMUNE INC ownership

NEXIMMUNE INC's ticker is NEXI and the CUSIP is 65344D109. A total of 47 filers reported holding NEXIMMUNE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEXIMMUNE INC
ValueSharesWeighting
Q3 2023$1,342
-25.6%
6,390
-0.0%
0.00%
Q2 2023$1,803
+90050.0%
6,392
-1.9%
0.00%
Q1 2023$20.0%6,515
-0.3%
0.00%
Q4 2022$2
-100.0%
6,534
-53.1%
0.00%
Q3 2022$8,000
+14.3%
13,921
+219.8%
0.00%
Q2 2022$7,000
-73.1%
4,353
-28.9%
0.00%
Q1 2022$26,000
+100.0%
6,122
+116.5%
0.00%
Q4 2021$13,000
+62.5%
2,828
+443.8%
0.00%
Q3 2021$8,000
-63.6%
520
-62.2%
0.00%
-100.0%
Q2 2021$22,000
+340.0%
1,377
+473.8%
0.00%
Q1 2021$5,0002400.00%
Other shareholders
NEXIMMUNE INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALLEN OPERATIONS LLC 635,934$10,378,0001.78%
Slate Path Capital LP 925,000$15,096,0000.84%
BRIDGER MANAGEMENT, LLC 400,000$6,528,0000.61%
Artal Group S.A. 1,200,000$19,584,0000.40%
DSAM Partners (London) Ltd 89,500$1,461,0000.24%
SUVRETTA CAPITAL MANAGEMENT, LLC 365,762$5,969,0000.09%
TimesSquare Capital Management, LLC 482,100$7,868,0000.06%
Johns Hopkins University 26,919$439,0000.05%
683 Capital Management, LLC 60,000$979,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 704,371$11,495,0000.02%
View complete list of NEXIMMUNE INC shareholders